New Delhi: Actuated by maturation in key emerging markets, India’s leading pharmaceutical company Ranbaxy Laboratories’ net profit for the quarter ended June 30 climbed up 118 percent to Rs 266.2 crore from Rs 122.11 crore in the corresponding period of the last year.
The company’s business in the rising market segments developed 44 per cent in the quarter, adding as much as 54 percent to its worldwide sales.
Larsen & Toubro ascended 2.81% to Rs 2,395 in afternoon trading after announcing a 139.83% increase in net earnings in Q1 June 2007 quarter. It announced the quarterly results during market hours today, 19 July 2007.
During the day, the scrip touched an intraday high of Rs 2,420 and an intraday low of Rs 2,350. On 13 July 2007, the stock has had its 52-week high of Rs 2,450 and a 52-week low of Rs 978 on 24 July 2006.
Reliance Energy recorded a 25.45% enhancement in net profit to Rs 2,215.60 million for the quarter ended June 2007 from Rs 1,766.10 million in the corresponding period ended June 2006.
or the first quarter ended June 2007, Pune-based Tech Mahindra’s conso
& Chemicals g
New Delhi: Actuated by maturation in key emerging markets, India’s leading pharmaceutical company Ranbaxy Laboratories’ net profit for the quarter ended June 30 climbed up 118 percent to Rs 266.2 crore from Rs 122.11 crore in the corresponding period of the last year. 
Finolex Cables arose 0.66% to Rs 99.50 on recording 41% growth in net earnings in 
Larsen & Toubro ascended 2.81% to Rs 2,395 in afternoon trading after announcing a 139.83% increase in net earnings in Q1 June 2007 quarter. It announced the quarterly results during market hours today, 19 July 2007. 
Reliance Energy recorded a 25.45% enhancement in net profit to Rs 2,215.60 million for the quarter ended June 2007 from Rs 1,766.10 million in the corresponding period ended June 2006.
